Clinical Trial: Valproate-Induced Lysine Valproylation: A Novel Post-Translational Modification and Its Epigenetic Regulatory Mechanisms (China)

China, Aug. 27 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Valproate-Induced Lysine Valproylation: A Novel Post-Translational Modification and Its Epigenetic Regulatory Mechanisms'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130882

Registration Time: 2026/08/26

Type: Interventional study

Primary Sponsor: Zhejiang Provincial People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=308247

Published by HT Digital Content Services with permission from Health Daily Digest....